Contents
Academic literature on the topic 'Addictovigilance'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Addictovigilance.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Addictovigilance"
Jouanjus, Emilie, Joëlle Micallef, Michel Mallaret, and Maryse Lapeyre-Mestre. "Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions." International Journal of Neuropsychopharmacology 22, no. 8 (June 13, 2019): 528–30. http://dx.doi.org/10.1093/ijnp/pyz033.
Full textChavant, François, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul, and Danièle Debruyne. "New Synthetic Drugs in Addictovigilance." Therapies 70, no. 2 (March 2015): 179–89. http://dx.doi.org/10.2515/therapie/2015001.
Full textChavant, François, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul, and Danièle Debruyne. "Nouvelles drogues de synthèse en addictovigilance." Therapies 70, no. 2 (March 2015): 167–78. http://dx.doi.org/10.2515/therapie/2014235.
Full textJouanjus, Emilie, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu, and Amélie Daveluy. "Comment identifier un signal en addictovigilance ?" Therapies 70, no. 2 (March 2015): 113–22. http://dx.doi.org/10.2515/therapie/2015009.
Full textDaveluy, Amélie, Joëlle Perri-Plandé, Marie Baumevieille, Alexandre Peyré, and Ghada Miremont-Salamé. "Addictovigilance dans les départements d’Outre-Mer." Therapies 73, no. 6 (December 2018): 565. http://dx.doi.org/10.1016/j.therap.2018.09.062.
Full textGibaja, Valérie, Audrey Fresse, Juliana Tournebize, and Maryse Lapeyre Mestre. "Poudre d’opium et addictovigilance : état des lieux." Therapies 76, no. 2 (March 2021): 164. http://dx.doi.org/10.1016/j.therap.2021.01.015.
Full textGentile, Gaétan, Maeva Jego, Michel Spadari, Karolina Griffiths, Emilie Jouanjus, and Joëlle Micallef. "Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?" Fundamental & Clinical Pharmacology 32, no. 6 (August 5, 2018): 643–51. http://dx.doi.org/10.1111/fcp.12401.
Full textLapeyre-Mestre, Maryse. "Identification and tracking of addictovigilance signals in general practice: which interactions between the general practitioners and the French addictovigilance network?" Fundamental & Clinical Pharmacology 32, no. 6 (November 11, 2018): 641–42. http://dx.doi.org/10.1111/fcp.12425.
Full textJouanjus, Emilie, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu, and Amélie Daveluy. "Signal Identification in Addictovigilance: the Functioning of the French System." Therapies 70, no. 2 (March 2015): 123–31. http://dx.doi.org/10.2515/therapie/2015011.
Full textBatisse, A., C. Eiden, R. Le Boisselier, J. Tournebize, A. Boucher, B. Fauconneau, S. Deheul, et al. "New psychoactive substances: French addictovigilance data between 2009 and 2017." Toxicologie Analytique et Clinique 31, no. 2 (May 2019): S42—S43. http://dx.doi.org/10.1016/j.toxac.2019.03.057.
Full textDissertations / Theses on the topic "Addictovigilance"
Pauly, Vanessa. "Evaluation de l'abus et du détournement des médicaments psychoactifs en addictovigilance : analyse de bases de données hétérogènes." Thesis, Aix-Marseille 2, 2011. http://www.theses.fr/2011AIX20696.
Full textThe objective of this work was to analyze abuse, dependence and diversion of psychoactive medicines in real settings using jointly different indicators issued from mixed datasources in order to present a synthetic vision. The datasources used in this work are issued from the tools developed by the Centres for Evaluation and Information on Pharmacodependency (CEIP). They allow to measure directly drug abuse with specific populations of dependent patients or under opiate treatment (OPPIDUM (Observation of the Illicit Psychotropic Products or Diverted from their Medicinal Use) survey)). These tools also allow to measure the diversion via the measure of the phenomenon of “doctor shopping” (overlapping of prescriptions) and the measure of the number of patients presenting a deviant behaviour from general health insurance databases; then they measure diversion through falsified prescriptions presented at pharmacies (the OSIAP (Forged prescriptions indicating potential abuse) survey).This multisources approach has been firstly applied to analyse abuse and diversion of clonazepam (1st publication). This study has highlighted the emerging problem of diversion of clonazepam, after flunitrazepam and has also illustrated the difficulty of analysing with consistency the information gathered by these different datasources. A good system for controlling drug diversion and abuse has to allow analysing trends. We have so proposed a classification method aiming at revealing profile of subjects with deviant behaviour to use it on an evolutive manner so as to study diversion of methylphenidate on a four year period (2nd publication). This classification method has then been applied jointly with a method measuring the “doctor shopping” to analyse diversion of High Dosage Buprenorphine (HDB) (3rd publication). This study has revealed an important problem of diversion of HDB, has also demonstrated that the two methods were globally concordant and has allowed to evaluate their advantages for the controlling of the abuse and diversion of prescription drugs. These two last methods have then been analysed jointly with data from the OPPIDUM and OSIAP surveys to allow to study and compare diversion of benzodiazepine drugs (4th publication) and opioids drugs (5th publication). This multisource approach allows to limit biases linked to each method seen individually. Our work points out the relevance of such a multisources system to estimate the abuse of a prescription drug and to compare it with the other substances. Nevertheless, the development of such a system applied to the domain of the drug dependency is relatively new, and requires improvements concerning the integration of the other sources of data and the methodology used to join and synthetize the information obtained. Finally, such a system "multi-sources” has the potential to exist and to make a real contribution to the domain of the drug dependency in France
Omgba-Noah, André Christian. "L’économie morale de l’accompagnement médico-social : étude de deux dispositifs de lutte contre les addictions." Electronic Thesis or Diss., Bourgogne Franche-Comté, 2023. http://www.theses.fr/2023UBFCC038.
Full textThis thesis analyzes the orientation of the productive action of medico-social professionals based on the probability of a moral economy of support specific to this field of intervention. After having exposed and circumscribed the definitional framework in which this community of values fits, we rely on empirical work carried out in two systems for combating addictions (TAPAJ and the Aller-vers mobile team). The objective of this contribution is to try to show that these professionals are not moved only by a rational will which disposes them to apply, without mediation, the laws which govern their environment. They are also sometimes caught and seized in a universe bathed in emotions and affects, carrying their action into quasi-vocational dimensions. This moral economy, therefore, shapes the ethics of care which is a theoretical-practical philosophy mainly considering care as being at the heart of concerns